Event JSON
{
"id": "ba6cdc4c9af400622f8c3bc01eba3935cf1d35289cb5eb03353ce9a3bbbeb662",
"pubkey": "f261e77ed38c5a7c6cf34564b89b26bc002380ab3b4c2cab919e028030c393e7",
"created_at": 1746146475,
"kind": 1,
"tags": [
[
"r",
"https://www.foxnews.com/health/weight-loss-drugs-get-surprising-endorsement-from-global-health-giant"
],
[
"subject",
"Weight-loss drugs to get surprising endorsement from global health giant"
],
[
"published_at",
"1746145896"
],
[
"image",
"https://static.foxnews.com/foxnews.com/content/uploads/2025/05/gettyimages-2195158078.jpg"
],
[
"p",
"f261e77ed38c5a7c6cf34564b89b26bc002380ab3b4c2cab919e028030c393e7",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://static.foxnews.com/foxnews.com/content/uploads/2025/05/gettyimages-2195158078.jpg"
],
[
"t",
"conservative:perspective"
],
[
"summary",
"The WHO plans to back GLP-1s like Wegovy and Zepbound to treat obesity in adults, with a focus on improving access to these medications in low- and middle-income countries. The organization has been working on new recommendations for obesity prevention, care, and treatment, which are expected to be finalized by August or September 2025. The guidance will include information on how and when these medications can be integrated into a chronic care model."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7fs7wlkn33d8cm8ng4jt3xexhsqz8q9t8dxze2u3ncpgqvxrj0ns8zan0k\nhttps://static.foxnews.com/foxnews.com/content/uploads/2025/05/gettyimages-2195158078.jpg\nThe WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.\nhttps://www.foxnews.com/health/weight-loss-drugs-get-surprising-endorsement-from-global-health-giant",
"sig": "7cf77d6b33e80fced63ed7f43b0ac07cf73e6a5621d9c80a2f54a8e114c405bde1952ebad1a53ad51ca5e1149c5e94714e14210d93d6edf851d923683ac4681c"
}
